International

Curaleaf Responds to Aurora Circular; Reaffirms Offer as Best Path to Value Creation for Shareholders

The company’s response comes after Aurora’s board unanimously concluded that the takeover bid is not in the best interests of Aurora or its shareholders.

Aurora Cannabis Urges Shareholders to Reject Curaleaf's Hostile Bid

The company is warning that the Curaleaf bid is inadequate, undervalues Aurora, and puts shareholder value and future upside at risk.

Curaleaf Responds to Aurora Cannabis' Latest Attempt to Deflect From Shareholder Value Creation

Aurora’s selective statistics and misleading characterization of engagement do not obscure years of underperformance and lost shareholder value, Curaleaf states.

Aurora Cannabis Corrects Inaccurate Statements Made in Support of Curaleaf’s Hostile Bid

Aurora advised its shareholders to take no action regarding the Curaleaf offer at this time.

Aurora Cannabis Acquires Internode Pharma, HAP Pharma, Expanding Distribution Access to UK

The acquisitions further Aurora’s global medical cannabis growth.

Tilray Expands Cannabis Cultivation Capacity in Canada, Europe to Meet International Demand

The company expanded cultivation in Quebec and Portugal, increasing its total annual production capacity to approximately 275 metric tonnes.

Aurora Cannabis Urges Shareholders to Take No Action on Curaleaf’s Unsolicited Takeover Bid

The company claims Curaleaf’s hostile takeover bid is designed to pressure Aurora’s shareholders into a short-term decision for the benefit of Curaleaf shareholders.

Curaleaf Launches Takeover Bid to Acquire Aurora Cannabis, Invites Aurora Shareholders to Tender Bid

The company filed the formal offer and takeover bid circular, which will be delivered to Aurora shareholders.

Tilray Medical Accelerates Commercial Expansion in UK With Direct-to-Patient Launch

The launch, through Lyphe Clinic and Lyphe Dispensary, expands direct patient access to the company’s cannabis medicines across the U.K.

Canopy Growth Secures Renewed EU GMP Certification at Kincardine Cultivation Facility

The renewed certification maintains Kincardine’s role in Canopy Growth’s EU GMP flower supply chain as the European medical cannabis business grows.

Aurora Cannabis Rejects Curaleaf’s Claim It Refused to Engage in Acquisition Proposal

Aurora responded to Curaleaf’s intention to launch an unsolicited takeover bid, stating the proposal lacked details, but the company did not discourage an ongoing dialogue.

Curaleaf Intends to Launch Takeover Bid for Aurora Cannabis

Curaleaf is taking its proposal directly to Aurora shareholders after repeated attempts to engage privately failed to gain substantive discussions.

Page 1 of 69

Next Page